Vivan Therapeutics Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 21

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 16

Vivan Therapeutics General Information

Description

Developer of personalized therapeutics designed to transform cancer care. The company's technology follows the personal discovery process (PDP), a massive clinical trial for a single patient, where the genetic complexity of each patient's tumor network is engineered into a group of fruit flies and robotics are used to evaluate FDA-approved drugs, including non-cancer drugs, enabling cancer patients with better treatment recommendations and developing new diagnostics and decision support tools to make cancer treatment more effective.

Contact Information

Website
www.vivantx.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Unit 3, Part First Floor
  • The Westworks, White City Place, 195 Wood Lane
  • London W12 7FQ
  • England, United Kingdom
+44 020
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Vertical(s)
Corporate Office
  • Unit 3, Part First Floor
  • The Westworks, White City Place, 195 Wood Lane
  • London W12 7FQ
  • England, United Kingdom
+44 020

Vivan Therapeutics Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Vivan Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
16. Accelerator/Incubator Completed Generating Revenue
15. Accelerator/Incubator 14-Jul-2025 Completed Generating Revenue
14. Accelerator/Incubator 10-Feb-2025 Completed Generating Revenue
13. Accelerator/Incubator 01-Jan-2024 Completed Generating Revenue
12. Accelerator/Incubator 01-Jan-2024 Completed Generating Revenue
11. Accelerator/Incubator Completed Generating Revenue
10. Later Stage VC (Series 2) 30-Dec-2024 Completed Generating Revenue
9. Grant 05-Oct-2022 Completed Generating Revenue
8. Grant 05-Oct-2020 $469K $1.46M Completed Generating Revenue
7. Early Stage VC $74.5K $1.46M Completed Pre-Clinical Trials
To view Vivan Therapeutics’s complete valuation and funding history, request access »

Vivan Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Preference
Preference
Preference
Ordinary A
Preference
Ordinary A
Preference
Preference
Ordinary 4,062 $0.001264 $103.14 $103.14 1x $103.14 1.84%
Preference 297 $0.001264 $103.67 $103.67 1x $103.67 0.13%
To view Vivan Therapeutics’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Vivan Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of personalized therapeutics designed to transform cancer care. The company's technology follows the personal
Biotechnology
London, United Kingdom
21 As of 2026

San Diego, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Vivan Therapeutics Competitors (1)

One of Vivan Therapeutics’s competitors is CureMatch, a Venture Capital-Backed company based in San Diego, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
CureMatch Venture Capital-Backed San Diego, CA
You’re viewing 1 of 1 competitors. Get the full list »

Vivan Therapeutics Patents

Vivan Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4444299-A1 A combination treatment for cancer Pending 06-Dec-2021
US-20250032494-A1 A combination treatment for cancer Pending 06-Dec-2021
WO-2023105286-A1 A combination treatment for cancer Inactive 06-Dec-2021
EP-4333818-A1 Model optimized drug and drug combinations for treating cancers Inactive 04-May-2021
US-20240216546-A1 Model optimized drug and drug combinations for treating cancers Pending 04-May-2021 A61K49/0008
To view Vivan Therapeutics’s complete patent history, request access »

Vivan Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Vivan Therapeutics Investors (16)

Investor Name Investor Type Holding Investor Since Participating Rounds
Nevcap Accelerator/Incubator Minority
Hub71 Accelerator/Incubator Minority
Arben Ventures Venture Capital Minority
Freya Ventures Venture Capital Minority
Reflect Ventures Venture Capital Minority
You’re viewing 5 of 16 investors. Get the full list »

Vivan Therapeutics FAQs

  • When was Vivan Therapeutics founded?

    Vivan Therapeutics was founded in 2018.

  • Where is Vivan Therapeutics headquartered?

    Vivan Therapeutics is headquartered in London, United Kingdom.

  • What is the size of Vivan Therapeutics?

    Vivan Therapeutics has 21 total employees.

  • What industry is Vivan Therapeutics in?

    Vivan Therapeutics’s primary industry is Biotechnology.

  • Is Vivan Therapeutics a private or public company?

    Vivan Therapeutics is a Private company.

  • What is Vivan Therapeutics’s current revenue?

    The current revenue for Vivan Therapeutics is .

  • How much funding has Vivan Therapeutics raised over time?

    Vivan Therapeutics has raised $5.97M.

  • Who are Vivan Therapeutics’s investors?

    Nevcap, Hub71, Arben Ventures, Freya Ventures, and Reflect Ventures are 5 of 16 investors who have invested in Vivan Therapeutics.

  • Who are Vivan Therapeutics’s competitors?

    CureMatch is a competitor of Vivan Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process